Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123,180,519
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
25,299,931
-
Shares change
-
+2,025,486
-
Total reported value, excl. options
-
$49,329,000
-
Value change
-
+$4,788,629
-
Number of buys
-
23
-
Number of sells
-
18
-
Price
-
$1.95
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q1 2017
As of 31 Mar 2017 CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) had 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 25,299,931 shares of stock of the company.
Largest 10 holders included Broadfin Capital, LLC, BAKER BROS. ADVISORS LP, venBio Select Advisor LLC, VANGUARD GROUP INC, Point72 Asset Management, L.P., Candriam Luxembourg S.C.A., BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, and Knott David M.
This table shows 62 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.